University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

Long-term Stability of LFP Recorded From the STN and the Effects of DBS

Completed

Conditions: Parkinson's Disease

Interventions: Device: PC+S group

First Posted Date: 2016-09-27

Last Posted Date: 2021-04-27

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 10

Registration Number: NCT02915848

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

Reducing Sedentary Behaviour With Technology

Not Applicable

Completed

Conditions: Prostate Cancer
Breast Cancer
Sedentary Behaviour
Fatigue
Physical Activity

Interventions: Other: Wearable Technology - Garmin Vivosmart
Other: Wearable Technology - FitBit Alta
Other: Online Educational Group
Other: Wearable Technology - Polar Loop 2

First Posted Date: 2016-09-22

Last Posted Date: 2021-04-13

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 28

Registration Number: NCT02911649

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Ontario-wide Cancer TArgeted Nucleic Acid Evaluation

Recruiting

Conditions: Colorectal Cancer
Breast Cancer
Lung Cancer
Melanoma
Genitourinary Cancer
Gynecological Cancer
Gastrointestinal Cancer
Head and Neck Cancer
Pancreatobiliary Cancer
Unknown Primary Cancer

First Posted Date: 2016-09-20

Last Posted Date: 2024-12-04

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 10000

Registration Number: NCT02906943

Locations: 🇨🇦
Kingston General Hospital, Kingston, Ontario, Canada
🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
🇨🇦
London Health Sciences Centre, London, Ontario, Canada

and more 4 locations

Mobile Health Technology for Chronic Kidney Disease Patients: Medication Management

Not Applicable

Completed

Conditions: Medication Reconciliation
Renal Insufficiency, Chronic
Hypertension
Mobile Applications

Interventions: Other: Usual Care
Device: Integrated mobile medication app
Device: Commercially available mobile medication app

First Posted Date: 2016-09-19

Last Posted Date: 2017-11-09

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 182

Registration Number: NCT02905474

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Local Anesthetic for Total Mastectomy Surgery

Phase 4

Conditions: Breast Pain

Interventions: Drug: Local Anesthetic Injection above the serratus anterior

First Posted Date: 2016-09-08

Last Posted Date: 2016-09-08

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 40

Registration Number: NCT02893384

Gastric Ultrasound of Diabetic and Non-Diabetic Patients Following Preoperative Fasting Instructions

Conditions: Diabetes Mellitus Type 2
Diabetes Mellitus
Diabetes Mellitus Type 1
Diabetes

First Posted Date: 2016-09-05

Last Posted Date: 2020-01-18

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 240

Registration Number: NCT02888951

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

Liver Transplantation for Early Intrahepatic Cholangiocarcinoma

Phase 2

Terminated

Conditions: Intrahepatic Cholangiocarcinoma

Interventions: Procedure: Deceased donor Liver Transplantation

First Posted Date: 2016-08-25

Last Posted Date: 2024-12-13

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 2

Registration Number: NCT02878473

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Gastric Arterial Embolization for Weight Loss

Not Applicable

Conditions: Obesity

Interventions: Procedure: Embolization of Gastroepiploic Artery
Procedure: Embolization of Left Gastric Artery

First Posted Date: 2016-08-19

Last Posted Date: 2016-08-19

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 10

Registration Number: NCT02872740

Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors

Phase 1

Active, not recruiting

Conditions: NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive Patients
Esophageal Cancer
Ovarian Cancer
Synovial Sarcoma
Melanoma
Lung Cancer
Bladder Cancer
Liver Cancer

Interventions: Drug: Cyclophosphamide
Biological: TBI-1301
Drug: Fludarabine

First Posted Date: 2016-08-16

Last Posted Date: 2024-10-10

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 22

Registration Number: NCT02869217

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Living Donor Liver Transplantation for Unresectable Colorectal Cancer Liver Metastases

Not Applicable

Recruiting

Conditions: Colorectal Cancer
Liver Metastases

Interventions: Procedure: live donor liver transplantation

First Posted Date: 2016-08-12

Last Posted Date: 2024-06-18

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 20

Registration Number: NCT02864485

Locations: 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy